SAN ANTONIO, March 09, 2018 -- Harte Hanks (NYSE:HHS), a leader in customer relationships, experiences and interaction-led marketing, announced today that the company will release its fourth quarter and full year 2017 financial results after the market closes Thursday, March 15, 2018. Chief Executive Officer, Karen Puckett and Chief Financial Officer, Jon Biro will host a call to discuss the results with analysts at 5:00 p.m. Eastern Daylight Time.
To access an audio webcast, please use the link available in the Investors Events section of the Harte Hanks website. The conference call number is (800)-239-9838 for domestic callers and +1 (323)-794-2551 for international callers. The conference ID is 8305260.
An audio replay will be available shortly after the call through Saturday, April 7, 2018 at (844) 512-2921, or +1 (412) 317-6671, with conference ID 8305260. The replay also will be available for one year in the Investors section of the Harte Hanks website.
About Harte Hanks:
Harte Hanks is a global marketing services firm specializing in multi-channel marketing solutions that connect our clients with their customers in powerful ways. Experts in defining, executing and optimizing the customer journey, Harte Hanks offers end-to-end marketing services including consulting, strategic assessment, data, analytics, digital, social, mobile, print, direct mail and contact center. From visionary thinking to tactical execution, Harte Hanks delivers smarter customer interactions for some of the world's leading brands. Harte Hanks 5,000+ employees are located in North America, Asia-Pacific and Europe. For more information, visit Harte Hanks at www.hartehanks.com, call 800-456-9748, email us at [email protected]. Follow us on Twitter @hartehanks or Facebook at https://www.facebook.com/HarteHanks.
As used herein, “Harte Hanks” refers to Harte Hanks, Inc. and/or its applicable operating subsidiaries, as the context may require. Harte Hanks’ logo and name are trademarks of Harte Hanks.
Investor and Media Contact:
Scott Hamilton
(303) 214-5563
[email protected]


TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade
Anta Sports Expands Global Footprint With Strategic Puma Stake
Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Washington Post Publisher Will Lewis Steps Down After Layoffs
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions 



